Literature DB >> 925259

Unpredictability of theophylline saliva measurements in chronic obstructive pulmonary disease.

L Hendeles, S Burkey, L Bighley, R Richardson.   

Abstract

The use of saliva as an indirect, non-invasive method of theophylline plasma level measurement was evaluated in 23 older men with chronic obstructive pulmonary disease and numerous concurrent medical problems. Simultaneously collected plasma and saliva samples were obtained on two or more occasions and analyzed for theophylline concentration by the Schack and Waxler spectrophotometric method. The mean (+/- SD) plasma:saliva ratio for 84 sample sets was 1.6 (+/- 0.5) with the saliva concentration averaging 64.8% (+/- 20.8%) of the plasma concentration. Multiplying a randomly chosen plasma:saliva ratio from each patient by the saliva concentration of a second randomly selected observation resulted in a predicted plasma concentration that differed by more than 20% of the measured concentrations for 16 of the 23 patients. Thus, use of saliva theophylline measurements obtained by the Schack and Waxler method to adjust dosage regimens cannot be recommended in these patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 925259     DOI: 10.1016/0091-6749(77)90063-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

Review 1.  Monitoring serum theophylline levels.

Authors:  L Hendeles; M Weinberger; G Johnson
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

2.  Relationship between serum and saliva chloramphenicol concentrations.

Authors:  J R Koup; A H Lau; B Brodsky; R L Slaughter
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

3.  A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants.

Authors:  Laura Hutchinson; Marlene Sinclair; Bernadette Reid; Kathryn Burnett; Bridgeen Callan
Journal:  Br J Clin Pharmacol       Date:  2018-03-25       Impact factor: 4.335

4.  Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined.

Authors:  C Knott; M Bateman; F Reynolds
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

5.  Relationship between saliva and free and total plasma theophylline concentrations in patients with chronic airflow obstruction.

Authors:  P Ebden; D Leopold; D Buss; A P Smith; P A Routledge
Journal:  Thorax       Date:  1985-07       Impact factor: 9.139

Review 6.  Sustained release theophylline preparations. Practical recommendations for prescribing and therapeutic drug monitoring.

Authors:  A Glynn-Barnhart; M Hill; S J Szefler
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 7.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

Review 8.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

9.  Correlation of serum and saliva theophylline concentration after administration of a sustained release preparation.

Authors:  J H Jonkman; G H Koëter; R Schoenmaker; K de Vries; J E Greving; R A de Zeeuw
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.